Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Fletcher

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The American Review of Respiratory Disease|March 1, 1991
Rate of oxyhemoglobin desaturation in obstructive versus nonobstructive apneaE C Fletcher, S Goodnight-White, D Munafo, et al.
Sleep Medicine|November 1, 2003
Hypercoagulability in patients with obstructive sleep apneaJ J Guardiola, P J Matheson, L C Clavijo, et al.
Chest|April 1, 1989
Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleepE C Fletcher, R A Luckett, T Miller, et al.
The American Review of Respiratory Disease|August 1, 1991
Evolution of nocturnal oxyhemoglobin desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm HgE C Fletcher, D Scott, W Qian, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 1999
Pulmonary edema develops after recurrent obstructive apneasE C Fletcher, M Proctor, J Yu, et al.
Chest|May 1, 1992
Lactate kinetics in severe COPD. Implications of an abnormal aminopyrine breath testS J Goodnight-White, C C Miller, S E Haber, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1990
Atelectasis affects the rate of arterial desaturation during obstructive apneaE C Fletcher, S Goodnight, T Miller, et al.
The American Review of Respiratory Disease|May 1, 1992
A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm HgE C Fletcher, R A Luckett, S Goodnight-White, et al.
Chest|March 1, 1992
Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturationE C Fletcher, C F Donner, B Midgren, et al.
JAMA|February 12, 1997
Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study GroupA M Fein, G R Bernard, G J Criner, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The American Review of Respiratory Disease|March 1, 1991
Rate of oxyhemoglobin desaturation in obstructive versus nonobstructive apneaE C Fletcher, S Goodnight-White, D Munafo, et al.
Sleep Medicine|November 1, 2003
Hypercoagulability in patients with obstructive sleep apneaJ J Guardiola, P J Matheson, L C Clavijo, et al.
Chest|April 1, 1989
Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleepE C Fletcher, R A Luckett, T Miller, et al.
The American Review of Respiratory Disease|August 1, 1991
Evolution of nocturnal oxyhemoglobin desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm HgE C Fletcher, D Scott, W Qian, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 1999
Pulmonary edema develops after recurrent obstructive apneasE C Fletcher, M Proctor, J Yu, et al.
Chest|May 1, 1992
Lactate kinetics in severe COPD. Implications of an abnormal aminopyrine breath testS J Goodnight-White, C C Miller, S E Haber, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1990
Atelectasis affects the rate of arterial desaturation during obstructive apneaE C Fletcher, S Goodnight, T Miller, et al.
The American Review of Respiratory Disease|May 1, 1992
A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm HgE C Fletcher, R A Luckett, S Goodnight-White, et al.
Chest|March 1, 1992
Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturationE C Fletcher, C F Donner, B Midgren, et al.
JAMA|February 12, 1997
Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study GroupA M Fein, G R Bernard, G J Criner, et al.
Pageof 8